Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA

Oral Zinc Supplementation Decreases the Risk of HCC Development in Patients With HCV Eradicated by DAA

We have reported that the plasma zinc concentration gradually decreases with the progression of fibrosis and is related to hepatocellular carcinoma (HCC) development. The aim of this study was to examine the impact of the zinc concentration on HCC development (study 1) and the relationship between z...

Full description

Saved in:
Bibliographic Details
Main Authors: Atsushi Hosui, Takashi Tanimoto, Toru Okahara, Munehiro Ashida, Kohsaku Ohnishi, Yuhei Wakahara, Yukihiro Kusumoto, Toshio Yamaguchi, Yuka Sueyoshi, Motohiro Hirao, Takuya Yamada, Naoki Hiramatsu
Format: article
Language:EN
Published: Wiley 2021
Subjects:
Diseases of the digestive system. Gastroenterology
RC799-869
Online Access:https://doaj.org/article/23a7b131d71d4caa81c6716491de355b
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/23a7b131d71d4caa81c6716491de355b

Similar Items